HaploX Biotechnology Funding: $32M Raised, Series A (2018)
HaploX Biotechnology is based in Shenzhen, China. It has raised $32M in total funding. Latest round: Series A.
HaploX Biotechnology funding overview
HaploX Biotechnology is based in Shenzhen, China. HaploX Biotechnology has raised $32M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2018. The round record for HaploX Biotechnology runs through 2018; nothing later has been disclosed. Investors on record include SoftBank China, Shenzhen Capital Group. 2 distinct backers are named across the disclosed rounds.
HaploX Biotechnology at a glance
Total raised
$32M
Latest round
Series A
Latest round date
June 2018
Headquarters
Shenzhen, China
Notable investors
SoftBank China, Shenzhen Capital Group
Frequently asked about HaploX Biotechnology funding
How much has HaploX Biotechnology raised?
HaploX Biotechnology has raised $32M in total disclosed funding across the rounds on record.
Who has invested in HaploX Biotechnology?
SoftBank China, Shenzhen Capital Group are named among the investors backing HaploX Biotechnology.
What was the latest HaploX Biotechnology funding round?
The most recent disclosed round is a Series A, announced in June 2018.
Where is HaploX Biotechnology based?
HaploX Biotechnology is based in Shenzhen, China.
When did HaploX Biotechnology last raise?
The last disclosed HaploX Biotechnology round closed in June 2018 at Series A.
We update the HaploX Biotechnology record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Shenzhen and their backers are listed below.
